Ethical Compliance
AARTI PHARMALABS
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
medium
Revenue
0.2%
Debt
10.2%
Liquidity
0%
Revenue
Debt
Liquidity
0.2%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Sale of Pharmaceuticals and Nutraceuticals | ₹1,802.37 |
| Sale of services | ₹13.13 |
| Other Operating Revenue | ₹37.10 |
| Other Income | ₹0.62 |
Questionable
INR Crores
| Net Gain on Sale of Investments | ₹1.24 |
Non Compliant
INR Crores
| Interest Income | ₹3.04 |
INR Crores
| Revenue from Questionable Sources: | ₹1.24 |
| Revenue from Non Compliant Sources: | ₹3.04 |
| Total: | ₹4.28 |
| Total Revenue: | ₹1,857.50 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹4.28
₹1,857.50
= 0.2%
compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.
